A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.

Completed · Phase 3

Conditions studied: Hypertension

In brief

Comparison of the safety and efficacy of the combination of amlodipine/Benazepril to amlodipine monotherapy in patients with non-essential hypertension, not controlled on amlodipine alone.

Key facts

Study ID

NCT00171366

Run by

Novartis

People needed

1422

Starts

2004-07-01

Expected to finish

2005-07-01

Last updated by the study team

2016-04-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Outpatients 18 years of age or older.
• Male or female patients are eligible. Female patients must be either post-menopausal for one year or surgically sterile, or using effective, contraceptive methods such as barrier method with spermicide, or an intrauterine device.
• Patients with essential hypertension as measured by a validated device

You may not qualify if…

• Severe hypertension (DBP > 115 mmHg diastolic and/or SBP > 180 mmHg systolic).
• Other protocol-defined exclusion criteria may apply.

Where it is running

• Novartis Pharmaceuticals — East Hanover, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.